The impact of COVID-19 on the clinical trial.
The objective of this study was to explore the impact of the coronavirus disease 2019 epidemic on ongoing and upcoming drug clinical trials. Qualitative semi-structured interviews were conducted with clinical trial staff and clinical trial subjects were surveyed by questionnaire in this study. The r...
Main Authors: | Zhimin Chen, Liran Chen, Huafang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0251410 |
Similar Items
-
The appearance and increase in the quantity and proportion of the clinical research coordinator’s service fee in drug clinical trial research fund and its impact on trial quality
by: Liran Chen, et al.
Published: (2021-07-01) -
Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
by: Audisio, K., et al.
Published: (2022) -
COVID-19 Clinical Trials
by: Bonnie Ky, MD, MSCE, et al.
Published: (2020-06-01) -
Assessing the impact of COVID‐19 on registered interventional clinical trials
by: Nour Hawila, et al.
Published: (2021-05-01) -
Managing oncology clinical trials during COVID-19 pandemic
by: Roberto J. Arai, et al.
Published: (2020-09-01)